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Abstract
Many of the molecular and cellular mechanisms discovered to regulate skele-
tal muscle hypertrophy were first identified using the rodent synergist ablation 
model. This model reveals the intrinsic capability and necessary pathways of skel-
etal muscle growth in response to mechanical overload (MOV). Reminiscent of 
the rapid cellular growth observed with cancer, we hypothesized that in response 
to MOV, skeletal muscle would undergo metabolic programming to sustain in-
creased demands to support hypertrophy. To test this hypothesis, we analyzed 
the gene expression of specific metabolic pathways taken from transcriptomic 
microarray data of a MOV time course. We found an upregulation of genes in-
volved in the oxidative branch of the pentose phosphate pathways (PPP) and 
mitochondrial branch of the folate cycle suggesting an increase in the produc-
tion of NADPH. In addition, we sought to determine the potential role of skeletal 
muscle- enriched microRNA (myomiRs) and satellite cells in the regulation of the 
metabolic pathways that changed during MOV. We observed an inverse pattern 
in gene expression between muscle- enriched myomiR- 1 and its known target 
gene glucose- 6- phosphate dehydrogenase, G6pdx, suggesting myomiR regula-
tion of PPP activation in response to MOV. Satellite cell fusion had a significant 
but modest impact on PPP gene expression. These transcriptomic findings sug-
gest the robust muscle hypertrophy induced by MOV requires enhanced redox 
metabolism via PPP production of NADPH which is potentially regulated by a 
myomiR network.
K E Y W O R D S
myomiR, NADPH, pentose phosphate pathway, redox metabolism, skeletal muscle 
hypertrophy
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1  |  INTRODUCTION
First described almost 60 years ago, the rodent synergist 
ablation model has been instrumental in identifying many 
of the cellular and molecular mechanisms involved in the 
regulation of skeletal muscle hypertrophy which were 
subsequently shown to be conserved in humans in re-
sponse to resistance exercise (Baar & Esser, 1999; Bodine 
et al., 2001; DeVol et al., 1990; Goldberg et al., 1975; 
Hornberger et al., 2006). In particular, synergist ablation 
has been reported to increase mouse plantaris muscle 
weight by 30%– 50% following 14  days of MOV (Roberts 
et al., 2020; Terena et al., 2017; Vechetti et al., 2019). The 
supra- physiological growth induced by synergist ablation- 
induced MOV reveals the remarkable intrinsic capability 
of skeletal muscle to hypertrophy. The identification of the 
metabolic processes that allow for such rapid and robust 
hypertrophic growth may provide insight that can be used 
to enhance the recovery of muscle following periods of 
disuse or under conditions in which the growth response 
to a hypertrophic stimulus is impaired such as with aging.
Metabolism has an essential role during cellular 
growth, whereby multiple pathways generate and provide 
the necessary requirements needed for anabolism (Zhu & 
Thompson, 2019). However, despite this evidence, during 
skeletal muscle hypertrophy the focus has primarily been 
on mTOR signaling, energy systems that rapidly produced 
ATP such as glycolysis and the phosphocreatine path-
way, and the energy sensor AMPK (Egan & Zierath, 2013; 
Hargreaves & Spriet, 2020; Kjobsted et al., 2018; Miyazaki 
& Esser, 2009). The role of metabolic reprograming during 
skeletal muscle growth has only recently been investi-
gated. For example, it was demonstrated the participation 
of important metabolic processes, such as the polyamine 
pathway, hexosamine biosynthetic pathway, and serine 
synthesis pathways play a role in skeletal muscle hypertro-
phy (Lambert et al., 2018; Stadhouders et al., 2020; Tabbaa 
et al., 2021). Therefore, overlooked metabolic networks 
may be contributing to the regulation of muscle mass.
MOV induces rapid and robust skeletal muscle growth 
which resembles the accelerated growth that occurs in 
cancer cells. It has been demonstrated that to be able to 
handle the high rates of growth, cancer cells alter their 
metabolism to rely more heavily upon the fermentation 
of glucose to lactate despite the presence of oxygen and 
functioning mitochondria (Hsu & Sabatini, 2008; Liberti 
& Locasale, 2016; Sun et al., 2018; Warburg et al., 1927). 
This metabolic phenomenon known as the Warburg Effect 
(first described by Otto Warburg) was initially thought 
to be critical for supplying ATP at a high rate necessary 
to support the rapid cell growth associated with cancer 
(Liberti & Locasale, 2016). This perspective has shifted in 
recent years to one in which the main purpose of aerobic 
glycolysis (Warburg Effect) is not ATP production per se 
but rather the generation of glycolytic intermediates that 
serve as precursors for the macromolecules (e.g., nucle-
otides, amino acid, and lipids) required for cell growth 
(Rosenzweig et al., 2018). In addition, metabolic repro-
graming could be a way in which redirecting metabolism 
modulates metabolic intermediates that subsequently 
dictates cellular behavior. This is seen in the control of 
epigenetics (Diehl & Muir, 2020), transcription factors 
(Li et al., 2018; Lu et al., 2002), enzymes (Maguire et al., 
2021), and increases in pathways which generate neces-
sary substrates needed to fuel tumor growth (Fan et al., 
2019). Together, these results suggest that metabolic re-
programming can induce a variety of cellular changes 
that could modify crucial signaling pathways related to 
growth. Since MOV- induced skeletal muscle hypertrophy 
stimulates a supra- physiological growth, we hypothesize 
that, similarly to the cancer cells, skeletal muscle fibers 
utilize aerobic glycolysis to support this rapid increase in 
size.
As an initial effort to test this hypothesis, we analyzed 
a microarray transcriptome time course analysis of MOV- 
induced muscle hypertrophy and focused on genes spe-
cifically associated glucose metabolism. In support of our 
hypothesis, we show the upregulation of genes known 
to have a central role in the pentose phosphate pathway 
(PPP) and one- carbon metabolism for the production 
of NADPH. We provide evidence for a role of muscle- 
enriched myomiR- 1 in the regulation of the PPP by target-
ing glucose- 6- phosphate dehydrogenase, G6pdx, a known 
target gene of myomiR- 1, and the rate limiting step of the 
PPP. Finally, we observed a modest response of PPP gene 
expression upon satellite cell fusion, providing evidence 
of the satellite- enriched myomiR- 206 as an additional reg-
ulator of skeletal muscle metabolism during MOV. The 
findings from our bioinformatics analyses identified can-
didate genes that warrant further investigation and their 
respective role in the metabolic programming that permits 
the robust hypertrophic growth induced by MOV.
2  |  METHODS
2.1 | Animals
All experimental procedures involving mice were ap-
proved by the University of Kentucky Institutional 
Animal Care and Use Committee. To deplete satellite 
cells, we crossed Pax7CreER/CreER mouse (stock no. 017763) 
to the Rosa26DTA/DTA mouse (stock no. 010527) (The 
Jackson Laboratory) to generate the Pax7- DTA mouse 
as previously described by us (Fry et al., 2014; McCarthy 
et al., 2011; Murphy et al., 2011). Mice were housed in a 
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temperature and humidity- controlled room and main-
tained on a 14:10- h light- dark cycle with food and water 
ad libitum.
2.2 | Experimental design
Adult (5  months old) female Pax7- DTA mice were ran-
domly assigned to receive either an intraperitoneal injec-
tion of tamoxifen (2.5 mg/day) or vehicle (15% ethanol in 
sunflower seed oil) for five consecutive days followed by 
a 2- week washout period. Following the washout period, 
vehicle- and tamoxifen- treated mice were then randomly 
assigned to sham or a synergist ablation surgery group 
with the plantaris muscle collected after 1, 3, 5, or 7 days 
(n = 5– 6/group).
2.3 | Synergist ablation
To induce skeletal muscle hypertrophy of plantaris mus-
cle via mechanical overload (MOV), a bilateral synergist 
ablation surgery which results in significant skeletal mus-
cle hypertrophy, was performed as previously described 
by our laboratory (Chaillou et al., 2013; Figueiredo et al., 
2019; Hamilton et al., 2014; McCarthy & Esser, 2007; 
Vechetti et al., 2019). Mice were anesthetized (3% isoflu-
rane with 1.5  L of O2 per minute), placed in sternal re-
cumbence where a small incision was made on the dorsal 
aspect of the lower hind limb with approximately half 
of the gastrocnemius and entire soleus muscle carefully 
excised. No apparent damage was observed to the neural 
and vascular supply of the plantaris muscle following the 
surgery. At the designated time point post- surgery, mice 
were euthanized via CO2 inhalation followed by cervical 
dislocation with the plantaris muscles excised, weighed, 
snap frozen in liquid nitrogen, and stored at −80°C until 
downstream analyses.
2.4 | RNA isolation
Total RNA was isolated from plantaris muscle previously 
frozen in liquid nitrogen. Samples were homogenized 
using a tissue homogenizer (Bullet Blender, Next Advance 
Inc.). Following homogenization, RNA was isolated via 
phase separation by the addition of bromochloropro-
pane (BCP) and centrifugation at 15,000 × g for 15 min. 
The supernatant containing RNA was then washed with 
the assistance of the Direct- zol™ Kit (Zymo Research). 
RNA was treated in- column with DNAse and eluted in 
nuclease- free water. The total RNA concentration and pu-
rity were assessed by measuring optical density (230, 260, 
and 280 nm) with a Nanodrop™ 2000/2000cSpectropho-
tometer (ThermoFisher Scientific).
2.5 | Microarray dataset analysis
The microarray analysis was carried out with pooled sam-
ples as previously described by us (Chaillou et al., 2013). 
Briefly, 250 ng of total RNA from a pool of 2 or 3 animals 
(same amount of total RNA), resulting in n = 2 per group, 
was used for each time point. The RNA was loaded onto 
the GeneChip™ Mouse Gene 1.0 ST array (Affymetrix). 
This microarray dataset is a part of another study by our 
laboratory (currently in preparation for submission) and 
has been deposited in the NCBI Gene Expression Omnibus 
database (GSE15 3542). Microarray analysis focused 
only on genes that are involved in metabolic pathways. 
Bioinformatics analyses of the dataset were performed 
in R (version 4.0.2) utilizing Bioconductor packages. 
Briefly, raw signal intensity data were downloaded and 
normalized with robust multi- array average (RMA) using 
GEOquery (Davis & Meltzer, 2007) and oligo (Carvalho & 
Irizarry, 2010) packages, respectively. Normalization con-
sisted in background correction, quantile normalization, 
and log2 transformation. For the detection of differentially 
expressed genes (DEG) related to metabolic pathways, 
we initially utilized microarray data from vehicle- treated 
mice to determine changes associated with the rapid 
growth induced by MOV. Having identified DEGs from 
vehicle- treated mice, we then adjusted our statistical de-
sign to include microarray data from tamoxifen- treated 
mice to determine if satellite cell depletion affected the 
change in metabolic- related gene expression identified 
in vehicle- treated mice in response to MOV. To identify 
DEGs, a linear model was fitted to the normalized data 
using Linear Models for Microarray Data (Limma) pack-
age (Ritchie et al., 2015). For vehicle- treated mice only 
analysis, DEGs were estimated using the empirical Bayes 
function with a false discovery rate (FDR) 5%, using the 
Benjamini– Hochberg method. For comparison between 
conditions (vehicle- treated vs. tamoxifen- treated), DEGs 
were detected using a group- mean parametrization with 
p  <  0.05 due to the small sample size of n  =  2 (pooled 
samples).
2.6 | MicroRNA expression
Reverse transcription reactions for myomiR- 206 and 
U6 small nuclear RNA (Rnu6) were performed with 
10  ng of total RNA using Taqman MicroRNA Reverse 
Transcription Kit (ThermoFisher Scientific) according to 
the manufacturer's directions. qPCR was carried out with 
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Taqman Gene expression Master Mix (2×) (ThermoFisher 
Scientific), TaqMan gene expression assay (miR- 206, 
#000510; Rnu6, #001973) using cDNA in a 10 µl reaction 
volume. qPCR was performed using the QuantStudio3 
(Applied Biosystems) qPCR system as described by the 
manufacturer. qPCR efficiency was calculated by linear 
regression during the exponential phase using LinRegPCR 
software v11.126 (Ruijter et al., 2009). The comparison of 
miRNAs expression between groups was determined fol-
lowing normalization with Rnu6. Relative quantification 
of miRNA expression was assessed by the ΔΔCT method 
relative to the control.
2.7 | In silico prediction of miRNA 
target genes
Target genes were detected using miRanda (Enright et al., 
2003) and RNAhybrid (Kruger & Rehmsmeier, 2006) 
software. Since individual tools use different features for 
miRNA:target interactions, we utilized a custom Python 
script to select only shared miRNA:target gene between 
the two software programs with a minimal free energy set 
as ΔG°= −18 kJ.
2.8 | Statistical analysis
The data are presented as means ± standard error. Except 
for transcriptomic data (statistical analyses discussed 
above), two- way ANOVA with Tukey post hoc analysis 
was used to test the effect of genotype and intervention 
on microRNA levels. Statistical analysis was performed 
with GraphPad Prism version 9.2.0 (GraphPad Software). 
Statistical significance was set at p < 0.05.
3  |  RESULTS
3.1 | Glycolytic pathway
To determine if aerobic glycolysis might be involved in 
providing the precursors for the macromolecules nec-
essary for the growth induced by MOV, we analyzed a 
microarray time course of MOV- induced muscle hyper-
trophy for genes known to be involved in metabolic path-
ways (Figure S1). Starting with glycolysis, we observed 
higher levels of genes involved with glucose uptake and 
intracellular phosphorylation (Glut1 and Hk2, respec-
tively) in response to MOV (Figure 1). Glut1 expression 
was higher throughout the time course, returning to base-
line by day 7, whereas Hk2 level was elevated on days 1 
and 3 but lower on days 5 and 7 of MOV. Downstream of 
Hk2, the level of the remaining genes involved in the glyc-
olytic pathway was either unchanged (Gapdh or Aldoa) or 
lower (Gpi, Pfkm, Pgk1, Pgam2, Pkm, and Eno3) at one or 
more time points during MOV (Figure 1). The change in 
the levels of glycolytic genes suggested that glucose were 
being diverted to adjacent central carbon pathways.
3.2 | Pentose phosphate pathway (PPP)
To determine if the PPP was activated during MOV- 
induced muscle hypertrophy, we analyzed genes of both 
the oxidative and the non- oxidative branches of the PPP. 
In the oxidative branch, the rate limiting enzyme G6pdx 
gene level was higher throughout the time course with 
the downstream genes Pgls and Pgd elevated on day 7 
and days 1 and 3 of MOV, respectively (Figure 2). For the 
non- oxidative branch, the gene level of Rpe and Rpia was 
not significantly different from sham whereas Tkt and 
Taldo1 were higher on days 3 and 5 of MOV (Figure 2). 
The increase in expression of G6pdx could lead to a sub-
sequent increase in NADPH production. NADPH is the 
reduced form of NADP+, therefore we sought to deter-
mine if Nadk1 (the kinase that phosphorylates NAD+), 
could concomitantly increase as well; possibly as a means 
to provide more substrate for G6pdx. We determined that 
the expression of Nadk1 was higher on days 1 and 3 of 
MOV (Figure 2).
3.3 | One- carbon metabolism
3.3.1 | Serine synthesis pathway (SSP)
The higher level of the genes associated with the oxidative 
branch of the PPP and Nadk1 suggested the production 
of NADPH was enhanced rather than de novo nucleotide 
synthesis in response to MOV. This finding motivated us 
to investigate if the levels of one- carbon metabolism genes 
involved in NADPH production and nucleotide synthesis 
(Newman & Maddocks, 2017) were also higher during 
MOV. We first looked at the serine synthesis pathway 
(SSP), as serine is used to generate the folate intermedi-
ate 5,10- methylenetetrahydrofolate, which participates in 
the production nucleotides and NADPH (Geeraerts et al., 
2021). We observed the level of serine synthesis pathway 
(SSP) genes which feeds serine into the folate cycle to gen-
erate NADPH, was altered with MOV. As shown in Figure 
3, the lack of a pattern in the expression of SSP genes 
Phdgh, Psat1, and Psph, suggested the de novo synthesis 
of serine was not elevated in response to MOV. However, 
level of the sodium- coupled neutral amino acid trans-
porter, Slc38a1, was higher on days 3, 5, and 7 of MOV 
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suggesting extracellular serine could be the source needed 
for downstream central carbon pathways (Figure 3).
3.3.2 | The folate cycle
The folate cycle is compartmentalized in the cytosol and 
mitochondria in which parallel reactions support one- 
carbon anabolic pathways (Ducker & Rabinowitz, 2017). 
The level of cytosolic Mthfd1 gene was lower throughout 
the time course suggesting the cytosolic compartment 
of the folate cycle was not participating in NADPH pro-
duction during MOV (Figure 3). In contrast, the level of 
mitochondrial Mthfd2 gene was highly elevated on days 
1 and 3 of MOV suggesting high levels of NADPH could 
be produced via the mitochondrial folate cycle (Figure 3). 
Furthermore, we found that the gene which encodes for 
a mitochondrial serine transporter, Sfnx1, was higher on 
days 3, 5, and 7 of MOV. This supports the elevation in 
Slc38a1 which could bring extracellular serine into the 
F I G U R E  1  Glucose uptake does not drive glycolysis during the rapid growth induced by mechanical overload (MOV). The glycolytic 
pathway is not utilized during MOV as demonstrated by the log twofold change (blue: upregulated, red: downregulated and black: not 
differentially expressed) in expression of the genes involved in glycolysis. N = 2/group (pooled samples). *denotes statistical significance 
(adjusted p value <0.05) compared to sham (control)
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cell which further gets pumped into the mitochondria for 
utilization of the folate pathway.
In terms of pathways related to reductive biosynthesis, 
we did not observe any significant change in the levels of 
genes involved in either fatty acid or amino acid synthesis, 
suggesting that these pathways were not altered at the 
transcript level in response to MOV (Figure S1). For nu-
cleotide synthesis, the lack of a consistent pattern in the 
gene expression in the non- oxidative branch of the PPP, 
made it difficult to determine if there was a change in de 
F I G U R E  2  Pentose Phosphate Pathway (PPP) is diverted from glycolysis during mechanical overload (MOV). PPP and Redox 
metabolism are upregulated during MOV as highlighted by log twofold change (blue: upregulated and black: not differentially expressed) of 
genes involved in these reactions. N = 2/group (pooled samples). *denotes statistical significance (adjusted p value <0.05) compared to sham 
(control)
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novo nucleotide synthesis. However, there was higher lev-
els of genes (Aprt, Nme, and Hprt) of the purine salvage 
pathway across the MOV time course (Figure S2), sug-
gesting the participation of the folate cycle in purine syn-
thesis. Additionally, Cmpk1, Rrm2, Ctps, Tyms, and Uck1 
were elevated at some time point during MOV (Figure S3). 
Finally, the elevated level of the neutral amino acid trans-
porter Slc38a10 on days 3, 5, and 7 of MOV may enhance 
pyrimidine synthesis by increasing intracellular gluta-
mine and aspartate levels (Figure S3).
3.4 | Redox metabolism
The elevated levels of genes of both the oxidative branch 
of the PPP and the mitochondrial folate cycle suggested 
higher NADPH synthesis in response to MOV. NADPH is 
used in redox homeostasis and reductive biosynthesis to 
produce fatty acids, amino acids, and nucleotides. NADPH 
plays a major role in cellular redox homeostasis by combat-
ing oxidative stress through reducing glutathione, thiore-
doxins, and peroxiredoxins. In response to MOV, Gsr, and 
F I G U R E  3  Serine and the folate cycle contribute additional NADPH during MOV: Serine may be generated via the serine synthesis 
pathway or brought into the cell by the sodium- coupled neutral amino acids transporter (Slc38a1). Serine can then participate in the 
generation of NADPH though the folate cycle. The mitochondrial compartment of the folate cycle is upregulated during MOV as highlighted 
by log twofold change (blue: upregulated and black: not differentially expressed) of genes involved in these reactions. N = 2/group (pooled 
samples). *denotes statistical significance (adjusted p value <0.05) compared to sham (control)
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Gpx1, which encode the two enzymes directly involved in 
glutathione reduction and oxidation, respectively, showed 
higher levels and suggest redox homeostasis was likely the 
primary process consuming NADPH (Figure 4). In addi-
tion, genes for thioredoxins and peroxiredoxins (Txnrd1 
and Prdx 1, respectively) involved in other redox pathways 
which can utilize NADPH to control hydrogen peroxide 
(H2O2) (Netto & Antunes, 2016) were also highly elevated 
during MOV (Figure 4).
3.5 | Potential regulation of metabolic 
genes by myomiR- 1 during MOV
MyomiR- 1 is the most abundant miRNA in the mouse 
plantaris muscle and shows the greatest change in 
expression in response to MOV of any miRNA (Vechetti 
et al., 2021). To determine if the higher levels of PPP and 
redox- related genes might be attributed to a decrease in 
myomiR- 1 expression, we performed a myomiR- 1 target 
gene prediction analysis on all of the significantly upreg-
ulated genes across the MOV time course. This analysis 
identified a small set of genes involved in the PPP, SSP, 
and redox homeostasis with predicted myomiR- 1 seed 
sequences within their respective 3'- UTR (Figure 5a). In 
particular, genes of the oxidative (G6pdx and Pgd) and 
non- oxidative (Tkt) branch of the PPP, SSP (Psat1), and 
redox homeostasis (Gsr and Gclc). Together, these results 
indicate a possible role of myomiR- 1 in the regulation of 
skeletal muscle metabolism by targeting key genes that 
act synergistically to produce and utilize NADPH during 
MOV.
F I G U R E  4  Redox metabolism 
is increased during MOV. Pathways 
related to the oxidation and reduction 
of glutathione are upregulated during 
MOV. In addition, other pathways that 
utilize NADPH to scavenge hydrogen 
peroxide increase during the first week 
of MOV as highlighted by log twofold 
change (blue: upregulated and black: not 
differentially expressed) of genes involved 
in these reactions. N = 2/group (pooled 
samples). *denotes statistical significance 
(adjusted p value <0.05) compared to 
sham (control)
   | 9 of 15VALENTINO et al.
3.6 | Influence of satellite cells on 
metabolism during MOV
We next wanted to determine if satellite cell fusion might 
be affecting the expression of PPP and redox homeostasis- 
related genes. We compared plantaris muscle gene expres-
sion of vehicle- treated, satellite cell- replete (SC+), and 
tamoxifen- treated, satellite cell- depleted (SC- ) to identify 
differentially expressed key metabolic genes across the 
MOV time course (Figure S4). Specifically, this analysis 
found that SC- G6pdx level was significantly higher on 
days 5 and 7 of MOV compared to SC+; in particular, 
SC- G6pdx level remained elevated while SC+G6pdx level 
was returning towards baseline on days 5 and 7 of MOV 
(Figure 5b).
Given that myomiR- 206 has been previously shown 
to be enriched in satellite cells (Fry et al., 2017), we hy-
pothesized that the expression of myomiR- 206, which is 
known to target many of the same genes as myomiR- 1 
given their identical seed sequence (Figure 5c), would be 
F I G U R E  5  Skeletal muscle metabolism regulated by a myomiR- 1 network. (a) In- silico prediction of myomiR- 1 metabolic target genes 
3’ UTR seed sequence and miyomiR- 1 (b) Expression of G6pdx in SC+ and SC- skeletal muscle throughout the time course (c) G6pdx 3'- UTR 
seed sequence and myomiR- 206 (d) myomiR expression throughout the time course. Log twofold change of DEGs between Vehicle- and 
Tamoxifen- treated mice after mechanical overload. N = 2/group (pooled samples) for (a- c), and n = 6 for (d). *denotes statistical significance 
(p value <0.05) between vehicle- and tamoxifen- treated mice
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higher in SC+compared to SC- and, as a result, repress 
expression of these genes upon satellite fusion starting 
at day 5 of MOV. In Figure 5d, qPCR analysis confirmed 
miR- 206 expression was higher at days 5 and 7 of MOV 
in the SC+group whereas miR- 206 expression did not 
change across the MOV time course in SC- group, con-
sistent with satellite cell proliferation and depletion, 
respectively.
4  |  DISCUSSION
We identified a potential mechanism which could facili-
tate the rapid growth response observed in MOV- induced 
skeletal muscle hypertrophy. Specifically, we identified 
the pentose phosphate pathway (PPP) as a possible shunt 
for glucose and highlighted the importance of the rate lim-
iting enzyme of the PPP, G6pdx, in the regulation of skel-
etal muscle metabolism during hypertrophy. In response 
to MOV, the results suggest the PPP becomes activated 
which leads to an increase in NADPH that is subsequently 
used in nucleotide biosynthesis and oxidative stress. We 
also provide evidence for a potential mechanism involving 
myomiRs modulating the expression of genes involved in 
the metabolic reprograming induced by MOV.
It is well established that the PPP is essential for re-
ductive biosynthesis and generation of NADPH (Vander 
Heiden et al., 2009). Pharmacological inhibition of G6pdx 
reduced nucleotide synthesis and tumor cell proliferation 
in both pancreatic adenocarcinoma cells and mice host-
ing Ehrlich's ascitic tumor cells (Boros et al., 1997). In 
contrast, overexpression of G6pdx was shown to increase 
the levels of NADPH resulting in a higher rate of cellu-
lar growth under oxidative stress (Tian et al., 1998). While 
these studies were not conducted in skeletal muscle, they 
support a critical role of G6pdx in cell growth. The impor-
tance of the PPP in skeletal muscle adaptation has been 
recently described by Hoshino and colleagues whereby 
electrical stimulation of C2C12 myotubes led to an in-
crease in reactive oxygen species- dependent activation of 
the PPP (Hoshino et al., 2020). The reliance on the PPP for 
muscle growth is also supported by studies investigating 
the rapid muscle growth of broiler chickens and in mice 
upon inducible, muscle- specific Akt- activation (Abasht 
et al., 2016; Brothers et al., 2019). Finally, Wagner and col-
leagues found increased levels of G6pdx and Pgd in mice 
after Marcaine- induced muscle damage indicating that 
the PPP is upregulated to assist in the recovery from mus-
cle damage (Wagner et al., 1978). Together, these studies, 
along with the results of the current study, suggest that the 
PPP is responsive to various stimuli and highlights the po-
tentially important role of this pathway in skeletal muscle 
hypertrophy and regeneration.
The PPP is not the only pathway which can generate 
NADPH, the folate and TCA cycles, malic enzymes, and 
nicotinamide nucleotide transhydrogenase mitochon-
drial inner membrane proteins can all generate NADPH 
(Ju et al., 2020). However, a previous study reported that 
in growing cells the PPP and folate cycle are the primary 
pathways responsible for NADPH production (Fan et al., 
2014), which agrees with our transcriptomic data. In par-
ticular, the transcriptomic data provides evidence that the 
mitochondrial branch of the folate cycle, compared to 
the cytosolic branch, could generate additional NADPH 
during MOV (Figure 4). Ducker and co- workers propose 
that the compartmentalization of the folate cycle is nec-
essary in order to uncouple one- carbon metabolism from 
glycolysis in an effort to preserve NAD+ and allow for the 
continuation of glycolysis (Ducker & Rabinowitz, 2017). 
Most recently Zhu and co- workers determined that mi-
tochondrial NADPH production was essential for the 
biosynthesis of proline, which contributed to collagen for-
mation (Zhu et al., 2021). Therefore, these findings indi-
cate that compartmentalizing NADPH synthesis could be 
a strategy by which the spatial production of a metabolic 
product ensures specific utilization.
It is well established that NADPH can be used to re-
duce oxidative stress with aberrant levels of NADPH asso-
ciated with cancer, cardiovascular disease, and aging (Ju 
et al., 2020; Xiao et al., 2018; Ying, 2008). In skeletal mus-
cle, it has been demonstrated that muscle contractions can 
increase both NADPH and ROS production (Henriquez- 
Olguin et al., 2019; Hoshino et al., 2020). Interestingly, 
increased levels of ROS can hydroxylate guanines of mRNA 
(Kasai et al., 1991; Shan et al., 2007), decreasing transla-
tional fidelity, causing ribosomal stalling and shortened 
peptides (Shan et al., 2007; Simms et al., 2014; Tanaka 
et al., 2007). Furthermore, oxidative modifications can 
occur on ribosomal proteins and ribosome modifying en-
zymes which may interfere with translation (Shcherbik 
& Pestov, 2019). NADPH production could also attenuate 
errors in protein synthesis by reducing the abundance of free 
radicals that would otherwise cause expression of genes 
associated with DNA damage, oxidized mRNA, and pro-
teolysis (Song et al., 2021). Altogether, increasing NADPH 
to reduce oxidative stress could allow for the high rate of 
protein synthesis that occurs during MOV and suggests 
that modulating NADPH could lead to improvements in 
protein synthesis.
Metabolic pathways are complex and regulated at sev-
eral levels with microRNAs shown to be involved in the 
regulation of glycolysis and the PPP (Singh et al., 2013; Xu 
et al., 2017). In addition, we and others have previously 
demonstrated that microRNAs play a role in skeletal mus-
cle plasticity (Bonanno et al., 2020; Hudson et al., 2014; 
Kovanda et al., 2018; McCarthy & Esser, 2007; Silva et al., 
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2019). For example, myomiR- 1, one of the most abundant 
microRNAs in skeletal muscle, decreases during skeletal 
muscle hypertrophy, suggesting this microRNA acts as a 
repressor of growth (Chaillou et al., 2013; McCarthy & 
Esser, 2007; Vechetti et al., 2021). Interestingly, myomiR- 1 
has also been shown to repress the activity of G6pdx re-
sulting in an inhibitory effect on the PPP (Singh et al., 
2013). Our results propose that the rapid downregulation 
of myomiR- 1 in response to MOV leads to enhanced lev-
els of G6pdx which, in turn, activates the PPP to generate 
NADPH. The concomitant increase in the levels of G6pdx 
with the decrease in myomiR- 1 may be the impetus for the 
metabolic shift observed during MOV.
It is well established that during MOV- induced mus-
cle hypertrophy, satellite cells fuse to the muscle fibers, 
contributing to the increase in myonuclei and poten-
tially playing other hypertrophic supporting roles (Fry 
et al., 2014; Kirby et al., 2016; Snijders et al., 2015). In 
order to determine if satellite cell fusion affects the lev-
els of G6pdx, during MOV- induced muscle hypertrophy, 
we queried a microarray comparing the metabolic genes 
between SC+ and SC- mice. We found that G6pdx was 
significantly elevated in SC- when compared to SC+mice 
(Figure 5b). Previous results from our laboratory sup-
ported a mechanism in which the delivery of satellite 
cell- enriched myomiR- 206- induced collagen remodeling 
during MOV (Fry et al., 2017). In addition, myomiR- 206 
has also been shown to regulate G6pdx in both C2C12 
myoblasts and cancer cells (Jiang et al., 2019; Singh et al., 
2013) as it shares a near identical seed region with my-
omiR- 1. The results from the current study demonstrate 
that myomiR- 206 expression is significantly elevated at 
days 5 and 7 of MOV only in SC+mice (Figure 5d) which 
coincided with the lower G6pdx expression in SC- muscle 
(Figure 5b). Together, these results suggest that satellite 
cell- enriched myomiR- 206 also participates in the met-
abolic reprograming during MOV- induced muscle hy-
pertrophy by modulating the levels of G6pdx. Although 
our results are based on changes in gene expression and 
microRNA target prediction, the regulation of G6pdx ex-
pression by myomiRs has been validated in cancer and 
nonneoplastic fibroblast cells (Singh et al., 2013), where 
an inverse correlation between myomiR- 1, −206 and PPP 
gene expression was demonstrated. Thus, we propose that 
myomiR- 1 and myomiR- 206 contribute to the metabolic 
reprograming that allows for the robust skeletal muscle 
growth observed in response to MOV by activating the 
PPP and one- carbon pathways.
The current study is not without limitations. The re-
sults rely exclusively on transcriptomic data to infer 
changes in metabolic pathways in response to MOV. A 
major focus of a future study will be to confirm the ob-
served changes in gene expression are reflected at the 
protein level. Previous studies have reported that changes 
in metabolic gene transcript levels correspond to similar 
changes at the protein level (Gupte et al., 2011; Hoshino 
et al., 2020; Singh et al., 2013; Weyrauch et al., 2020). In 
addition, Weyrauch and colleagues, using the same hy-
pertrophy model (i.e., MOV induced by synergist abla-
tion) as used in the current study, showed that GLUT1 
and G6PDH protein abundance as well as NADPH levels 
were all higher in response to 5 days of MOV (Weyrauch 
et al., 2020). This gives us confidence that the changes 
in gene expression observed here are also physiological 
meaningful. Additionally, samples were pooled for mi-
croarray analysis which limits the amount of biological 
variation in our results. This may limit the extent to which 
our results may be interpreted. Nonetheless, our results 
still provide novel data regarding metabolic networks 
that appear to be important for skeletal muscle growth 
and are not diminished by the methodology. For example, 
Mendias and co- workers performed a microarray analy-
sis on rat plantaris muscle after 3, 7, and 28s of synergist 
ablation (Mendias et al., 2017). RNA for this analysis was 
not pooled allowing for each sample (n = 4 per group) to 
be sequenced individually (Mendias et al., 2017). In line 
with our results, G6pdx was significantly higher on day 
3 compared to control (GSE62388), demonstrating con-
sistencies among microarray analysis strategies. Another 
potential limitation of the study is the fact that our tran-
scriptomic analysis encompasses the whole muscle and 
cannot distinguish the contribution of non- muscle cell 
types to the observed changes in gene expression. For in-
stance, macrophage abundance has been shown be sig-
nificantly elevated after 5 days of MOV which may have 
influenced the transcriptomic data given that macro-
phages undergo metabolic reprograming upon activation 
(Novak et al., 2009; O'Neill et al., 2016). This concern is 
tempered by the finding of Kirby and colleagues showing 
that approximately 90% of nascent RNA is associated with 
myonuclei during MOV induced by synergist ablation 
(Kirby et al., 2016), thus providing confidence that most 
of the observed changes in gene expression reflect what is 
occurring within muscle fibers.
In conclusion, we provide evidence to suggest the ro-
bust muscle growth induced by MOV may rely upon met-
abolic reprogramming that involves activation of the PPP 
and one- carbon metabolic pathway. Further, our data 
along with studies in cancer, indicate activation of the PPP 
is regulated by myomiR targeting of G6pdx (Coda et al., 
2015; Singh et al., 2013). The findings from this study pro-
vide the foundation for future studies focused on deter-
mining the role of G6pdx in skeletal muscle hypertrophy.
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